Secretome Analysis of Host Cells Infected with Toxoplasma gondii after Treatment of Human Epidermal Growth Factor Receptor 2/4 Inhibitors
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Toxoplasma gondii, a ubiquitous, intracellular parasite of the phylum Apicomplexa, infects an estimated one- third of the human population as well as a broad range of warm-blooded animals. We have observed that some tyrosine kinase inhibitors suppressed the growth of T. gondii within host ARPE-10 cells. Among them, afatinib, human epithermal growth factor receptor 2 and 4 (HER2/4) inhibitor, may be used as a therapeutic agent for inhibiting parasite growth with minimal adverse effects on host. In this report, we conducted a proteomic analysis to observe changes in host proteins that were altered via infection with T. gondii and the treatment of HER2/4 inhibitors. Secreting proteins were subjected to a procedure of micor basic reverse phase liquid chromatography, nano-liquid chromatography-mass spectrometry, and ingenuity pathway analysis serially. As a result, the expression level of heterogeneous nuclear ribonucleoprotein K, sema- phorin 7A, a GPI membrane anchor, serine/threonine-protein phosphatase 2A, and calpain small subunit 1 proteins were significantly changed, and which were confirmed further by western blot analysis. Changes in various proteins, including these 4 proteins, can be used as a basis for explaining the effects of T. gondii infections and HER2/4 inhibitors.
Abstract
Toxoplasma gondii, a ubiquitous, intracellular parasite of the phylum Apicomplexa, infects an estimated one- third of the human population as well as a broad range of warm-blooded animals. We have observed that some tyrosine kinase inhibitors suppressed the growth of T. gondii within host ARPE-10 cells. Among them, afatinib, human epithermal growth factor receptor 2 and 4 (HER2/4) inhibitor, may be used as a therapeutic agent for inhibiting parasite growth with minimal adverse effects on host. In this report, we conducted a proteomic analysis to observe changes in host proteins that were altered via infection with T. gondii and the treatment of HER2/4 inhibitors. Secreting proteins were subjected to a procedure of micor basic reverse phase liquid chromatography, nano-liquid chromatography-mass spectrometry, and ingenuity pathway analysis serially. As a result, the expression level of heterogeneous nuclear ribonucleoprotein K, sema- phorin 7A, a GPI membrane anchor, serine/threonine-protein phosphatase 2A, and calpain small subunit 1 proteins were significantly changed, and which were confirmed further by western blot analysis. Changes in various proteins, including these 4 proteins, can be used as a basis for explaining the effects of T. gondii infections and HER2/4 inhibitors.
참고문헌 (28)
- Tenter AM, "Toxoplasma gondii : from animals to humans", Int J Parasitol, 30, pp.1217~1258 (2000)
- Jackson MH, "The prevalence and source of Toxoplasma infection in the environment", Adv Parasitol, 28, pp.55~105 (1989)
- Chung WH, "Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis", Nat Med, 14, pp.1343~1350 (2008)
- Decoster A, "Recognition of Toxoplasma gondii excreted and secreted antigens by human sera from acquired and congenital toxoplasmosis : identification of markers of acute and chronic infection", Clin Exp Immunol, 73, pp.376~382 (1988)
- Darcy F, "Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted", secreted antigens from tachyzoites of Toxoplasma gondii, 1988, pp.10, 553~567
- Duquesne V, "Protection of nude rats against Toxoplasma infection by excreted-secreted antigen-specific helper T cells", Infect Immun, 58, pp.2120~2126 (1990)
- Rahmah N, "Demonstration of antigenic similarities and variations in excretory", secretory antigens of Toxoplasma gondii, 1992, pp.187, 294~298
- Zenner L, "Protective immunity in the rat model of congenital toxoplasmosis and the potential of excreted-secreted antigens as vaccine components", Parasite Immunol, 21, pp.261~272 (1999)
- Cesbron-Delauw MF, "Excreted", secreted antigens of Toxoplasma gondii--their origin and role in the host-parasite interaction, 1993, pp.144, 41~44
- Ossorio PN, "A soluble secretory protein of the intracellular parasite Toxoplasma gondii associates with the parasitophorous vacuole membrane through hydrophobic interactions", J Biol Chem, 269, pp.15350~15357 (1994)
- Hoppe HC, "Targeting to rhoptry organelles of Toxoplasma gondii involves evolutionarily conserved mechanisms", Nat Cell Biol, 2, pp.449~456 (2000)
- Prigione I, "T cell clones raised from chronically infected healthy humans by stimulation with Toxoplasma gondii excretory-secretory antigens cross-react with live tachyzoites : characterization of the fine antigenic specificity of the clones and implications for vaccine development", Immunol, 164, pp.3741~3748 (2000)
- Mercier C, "The amphipathic alpha helices of the Toxoplasma protein GRA2 mediate post-secretory membrane association", J Cell Sci, 111, pp.2171~2180 (1998)
- Nockemann S, "Expression, characterization and serological reactivity of a 41 kDa excreted-secreted antigen(ESA)from Toxoplasma gondii", Mol Biochem Parasitol, 97, pp.109~121 (1998)
- 이원규, "Comprehensive Proteome Analysis of the Excretory", Secretory Proteins of Toxoplasma gondii, 2014, pp.35(10), 3071~3076[DOI]
- Zhaoshou Yang, "Afatinib Reduces STAT6 Signaling of Host ARPE-19 Cells Infected with Toxoplasma gondii", Parasites, Hosts and Diseases, 54(1), pp.31~38 (2016), 대한기생충학ㆍ열대의학회
- Zhaoshou Yang, "Gefitinib inhibits the growth of Toxoplasma gondii in HeLa cells", Parasites, Hosts and Diseases, 52(4), pp.439~441 (2014), 대한기생충학ㆍ열대의학회[DOI]
- 김영훈, "Suppressors for Human Epidermal Growth Factor Receptor 2", 4 (HER2, Parasites, Hosts and Diseases, pp.2017, 55(5)[DOI]
- 송경주, "Anti-Apoptotic Effects of SERPIN B3 and B4 via STAT6 Activation in Macrophages after Infection with Toxoplasma gondii", Parasites, Hosts and Diseases, 50(1), pp.1~6 (2012), 대한기생충학ㆍ열대의학회
- Ahn HJ, "STAT6 activation by Toxoplasma gondii infection induces the expression of Th2 C-C chemokine ligands and B clade serine protease inhibitors in macrophage", Parasitol Res, 105, pp.1445~1453 (2009)
- Moumen A, "hnRNP K : an HDM2 target and transcriptional coactivator of p53 in response to DNA damage", Cell, 123, pp.1065~1078 (2005)
- Guo Z, "E-cadherin interactome complexity and robustness resolved by quantitative proteomics", Sci Signal, 7, pp.rs7~ (2014)
- Pasterkamp RJ, "Semaphorin 7A promotes axon outgrowth through integrins and MAPKs", Nature, 424, pp.398~405 (2003)
- Suzuki K, "Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin", Nature, 446, pp.680~684 (2007)
- Scott GA, "Semaphorin 7a promotes spreading and dendricity in human melanocytes through beta1-integrins", J Invest Dermatol, 128, pp.151~161 (2008)
- Isenberg J, "Peptidyl-prolyl cis-trans isomerase A-A novel biomarker of multi-episodic(recurrent)ocular toxoplasmosis", Exp Eye Res, 177, pp.104~111 (2018)
- Demarchi F, "Calpain as a novel regulator of autophagosome formation", Autophagy, 3, pp.235~237 (2007)
- Cataldo F, "CAPNS1 regulates USP1 stability and maintenance of genome integrity", Mol Cell Biol, 33, pp.2485~2496 (2013)